Egypt The Health Committee of the Egyptian House of Representatives is preparing to discuss a draft law from the government on the establishment of the “Egyptian Drug Authority.”   The new entity will specialise in all medicine-related issues, from pricing to shortages to registering new drugs.   Similarly to Europe’s European Medicine…

Egypt Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and cure’ model raises numerous questions.   Egypt has a long history struggling with Hepatitis C (HCV) that started in the…

Egypt With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease that costs the country thousands of lives and millions of dollars.     Egypt is believed to have the largest prevalences…

Turkey Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to harness their geographic positioning and export to developed and developing markets alike.   We did not shy away from entering the most advanced healthcare ecosystems. Barış Özyurtlu, General Manageger, Berko Ilac.…

Turkey Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and experience from former periods of economic fluctuation to push the Turkish healthcare and life sciences sector forward.   Turkey made…

Algeria With stiffening up of local content requirements well underway, many multinational drug developers seeking to introduce their therapies to the Algerian marketplace have been scrambling to team up with the handful of indigenous CMOs that possess the requisite quality standards and reputations to handle their brands. Here is a selection…

Algeria

Turkey With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism.   Turkey has always been a popular tourist destination, given its unrivaled history and cultural appeal, and now, after years of large-scale investments by both the private and public sector,…

Turkey In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young, ambitious export sector.   Turkey’s experiment with mandatory localisation policies for pharmaceutical and medical products production is paying off nicely.…

Algeria Key recent investments from Middle Eastern companies into Algerian Pharma.   Saudi company Tabuk Pharmaceuticals invests USD 20 million into a plant in Blida (2014) “We arrived in Algeria in 1997 with imports only. Then Tabuk partnered with the Central Pharmacy of Hospitals (PCH) in 2004. We had a renewed…

Algeria A sudden imposition of import restrictions on pharmaceuticals in 2017 has pushed several multinational companies to establish local production facilities in Algeria. However, the localization process can be fraught both for companies that establish direct manufacturing footprints via joint ventures and those that employ the services of local contract manufacturers.…

Algeria The global drop in oil prices in 2015-2016 hit the Algerian economy – which is heavily reliant on petroleum revenues – hard. The country’s government implemented severe economic cuts across a number of sectors  (including healthcare), to redress the balance, shuttering plans to create five new hospitals. With the multinational…